A Pragmatic Testing-Eligibility Framework for Population Mutation Screening: The Example of BRCA1/2.
Ana F BestMargaret A TuckerMegan N FroneMark H GreeneJune A PetersHormuzd A KatkiPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)
In general, this risk-based framework could provide useful new options to consider during eligibility-criteria development for population mutation screening.
Keyphrases